Immediate Impact
44 standout
Citing Papers
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
2024 Standout
Diagnosis and management of ANCA-associated vasculitis
2024 Standout
Works of Gilwan Kim being referenced
Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis
2016
Clinical and Economic Burden of Antineutrophil Cytoplasmic Antibody–associated Vasculitis in the United States
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Gilwan Kim | 70 | 52 | 202 | 117 | 81 | 25 | 426 | |
| Stefania Manganelli | 107 | 23 | 187 | 69 | 70 | 19 | 469 | |
| Filipe Araújo | 42 | 25 | 124 | 84 | 48 | 24 | 373 | |
| Mehmet Şahin | 60 | 35 | 112 | 47 | 59 | 32 | 455 | |
| Tunay Sarpel | 43 | 115 | 139 | 48 | 70 | 34 | 483 | |
| Dana L. Shires | 26 | 14 | 82 | 80 | 37 | 21 | 483 | |
| Valeria Nucera | 110 | 32 | 158 | 92 | 54 | 19 | 454 | |
| E. Di Cesare | 21 | 63 | 68 | 71 | 52 | 23 | 486 | |
| Ali Uğur Uslu | 29 | 19 | 116 | 100 | 37 | 26 | 415 | |
| Nick Wilkinson | 27 | 14 | 166 | 104 | 33 | 24 | 490 | |
| D Heldenberg | 55 | 66 | 53 | 26 | 24 | 33 | 413 |
All Works
Login with ORCID to disown or claim papers
Loading papers...